-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
EyePoint Pharmaceuticals, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2010 to Q1 2025.
- EyePoint Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $276K, a 76.9% decline year-over-year.
- EyePoint Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $4.05M, a 16.3% increase from 2023.
- EyePoint Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $3.48M, a 62% increase from 2022.
- EyePoint Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $2.15M, a 1278% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)